Search results for "cancer diagnosis"

Learn how Massachusetts General Hospital research lab is using plasma proteomics to enhance immunotherapy for melanoma

Gene and cell therapy expert Dr. Gerhard Bauer explores the powerful therapies that use a patient's own immune cells to treat cancer

Researchers at the University of Bern have now discovered which genes play an important role in the response to radiation therapy

Find out about the 'revolutionary' technology enabling one lab to provide higher-quality, more timely data for cancer researchers

Scientists are harnessing machine learning to make accurate measurements of breast cancer risk from a patient’s blood cells

Dr. Fang Xie shares insights from his research into prostate cancer and offers hope of overcoming the growing problem of chemotherapy resistance to improve patient outcomes

Watch this on-demand webinar to learn about the applications for cell-based therapies and biologics using advanced high-throughput flow cytometry

Learn how an institute in the US is developing the latest patient-derived 3D cancer cell cultures for use in precision medicine

Confocal images of co-culture spheroids were quantitatively analyzed using NoviSight™ software to evaluate their cell population and determine drug sensitivity in each cell

Leading biosciences companies will model patient data to further evaluate biomarkers in immuno-oncology studies

Superb diagnostics and performance

Dr. Martin Than shares how adoption of POC assays could enable rapid decision making, to help tackle overcrowding issues in emergency settings

Diadem announces publication of clinical data showing its AlzoSure biomarker test is able to predict progression to Alzheimer’s disease years before symptoms are displayed.

In this guest editorial, Microzone explores MRSA and the escalating crisis of antimicrobial resistance—demanding faster diagnostics, renewed stewardship, and urgent global action

Discover how Merck is working to shape the future of rapid diagnostics by advancing lateral flow tests and ensuring preparedness for future pandemics

A new, more sustainable AI model recognizes visual scenes by mirroring brain processes, opening doors for applications in medical diagnostics, drug discovery and beyond

New machine learning software can forecast the survival rates and response to treatments of patients with ovarian cancer

PD-L1 IHC 28-8 pharmDx will give more insight to which patients with urothelial cancer are most likely to benefit from Opdivo (nivolumab)

Collaboration with Mirati Therapeutics targets MET gene mutations to personalize treatment